Regeneron Pharmaceuticals (REGN)
Capital Expenditure
-$240.20M
Quarterly · Period ending: · USD
REGN Capital Expenditure
Latest reported-$240.20Mperiod ending
Latest reported-$240.20Mperiod ending
REGN Quarterly CapEx (-$100.00K → -$240.20M)
Quarterly CapEx
High-resolution chart · PNG
REGN capital expenditure history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -2,213,000 | |
| -1,643,000 | |
| -1,165,000 | |
| -1,041,000 | |
| -2,518,000 | |
| -1,771,000 | |
| -800,000 | |
| -1,200,000 | |
| -2,700,000 | |
| -1,000,000 | |
| -600,000 | |
| -1,300,000 | |
| -200,000 | |
| -900,000 | |
| -600,000 | |
| -400,000 | |
| 100,000 | |
| -1,200,000 | |
| -600,000 | |
| -500,000 | |
| -2,700,000 | |
| -4,800,000 | |
| -2,700,000 | |
| -400,000 | |
| -100,000 | |
| -100,000 | |
| 500,000 | |
| -700,000 | |
| -1,200,000 | |
| -5,500,000 | |
| -8,100,000 | |
| -1,200,000 | |
| -700,000 | |
| -200,000 | |
| 49,900,000 | |
| -50,800,000 | |
| -700,000 | |
| -500,000 | |
| -800,000 | |
| -100,000 |